ArticleBone marrow transplantation2025

Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.

Jesús Duque-Afonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.